Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124783932 | 12478393 | 2 | F | 20160622 | 20160618 | 20160813 | PER | US-ASTRAZENECA-2016SE55012 | ASTRAZENECA | 0.00 | F | Y | 0.00000 | 20160813 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124783932 | 12478393 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | Y | U | FM0154 | 206995 | 250 | MG | TABLET | QD | ||||
| 124783932 | 12478393 | 2 | SS | IRESSA | GEFITINIB | 1 | Oral | Y | U | FM0154 | 206995 | 250 | MG | TABLET | QD | ||||
| 124783932 | 12478393 | 3 | SS | IRESSA | GEFITINIB | 1 | Oral | Y | U | 206995 | 250 | MG | TABLET | QD | |||||
| 124783932 | 12478393 | 4 | SS | IRESSA | GEFITINIB | 1 | Oral | Y | U | 206995 | 250 | MG | TABLET | QD | |||||
| 124783932 | 12478393 | 5 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | 0 | TABLET | |||||||||
| 124783932 | 12478393 | 6 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | 0 | ||||||||||
| 124783932 | 12478393 | 7 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 124783932 | 12478393 | 8 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Unknown | 0 | |||||||||||
| 124783932 | 12478393 | 9 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | |||||||||||
| 124783932 | 12478393 | 10 | C | HYDROCHOLORTHIAZIDE | 2 | Unknown | 0 | ||||||||||||
| 124783932 | 12478393 | 11 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 0 | |||||||||||
| 124783932 | 12478393 | 12 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 0 | |||||||||||
| 124783932 | 12478393 | 13 | C | XARELTO | RIVAROXABAN | 1 | Unknown | 0 | |||||||||||
| 124783932 | 12478393 | 14 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | |||||||||||
| 124783932 | 12478393 | 15 | C | POTASSIUM | POTASSIUM | 1 | Unknown | 0 | |||||||||||
| 124783932 | 12478393 | 16 | C | CHLORPROMAZINE. | CHLORPROMAZINE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124783932 | 12478393 | 1 | Lung neoplasm malignant |
| 124783932 | 12478393 | 2 | Non-small cell lung cancer |
| 124783932 | 12478393 | 3 | Lung neoplasm malignant |
| 124783932 | 12478393 | 4 | Non-small cell lung cancer |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124783932 | 12478393 | Cough | |
| 124783932 | 12478393 | Diarrhoea | |
| 124783932 | 12478393 | Faeces discoloured | |
| 124783932 | 12478393 | Lacrimation increased | |
| 124783932 | 12478393 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124783932 | 12478393 | 1 | 20160420 | 0 | ||
| 124783932 | 12478393 | 2 | 20160420 | 0 |